Abstract
The role of GABA in synaptic transmission in the mammalian central nervous system is more firmly established than for any other neurotransmitter. With virtually every neuron studied, the synaptic action of GABA is mediated by bicuculline-sensitive GABAA receptors which selectively increase chloride conductance. However, it has been shown that GABA has a presynaptic inhibitory action on trasmitter release that is insenstive to bicuculline and is selectively mimicked by baclofen1. The receptors involved in this action are referred to as GABAB receptors, to distinguish them from the classic bicuculline-sensitive GABAA receptors. In hip-pocampal pyramidal cells an additional postsynaptic action of GABA and baclofen has been reported that is also insensitive to GABAA antagonists2,3, and may be mediated by GABAB receptors on the postsynaptic neuron. This action of GABA and baclofen involves an increase in potassium conductance2–7. Synaptic activation of pathways converging on hippocampal pyramidal cells results in a slow inhibitory postsynaptic potential which involves an increase in potassium conductance4,8,9, and it has been suggested that GABAB receptors might be responsible for this synaptic potential4. However, to establish convincingly that GABAB receptors are physiologically important in the central nervous system, a selective GABAB antagonist is required. Here we provide this missing evidence. Using the hippocampal slice preparation, we now report that the phosphonic acid derivative of baclofen, phaclofen10, is a remarkably selective antagonist of both the postsynaptic action of baclofen and the bicuculline-resistant action of GABA, and that it selectively abolishes the slow inhibitory postsynaptic potential in pyramidal cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hill, D. R. & Bowery, N. G. Nature 290, 149–152 (1981).
Newberry, N. R. & Nicoll, R. A. Nature 308, 450–452 (1984).
Blaxter, T. J. & Cottrell, G. A. Q. Jl exp. Physiol. 70, 75–93 (1985).
Newberry, N. R. & Nicoll, R. A. J. Physiol., Lond. 360, 161–185 (1985).
Gahwiler, B. H. & Brown, D. A. Proc. natn. Acad. Sci. U.S.A. 82, 1558–1562 (1985).
Inoue, M., Matsuo, T. & Ogata, N. Br. J. Pharmac. 84, 833–841 (1985).
Inoue, M., Matsuo, T. & Ogata, N. Br J. Pharmac. 86, 515–524 (1985).
Alger, B. E. J. Neurophysiol. 52, 892–910 (1984).
Hablitz, J. J. & Thalmann, R. H. J. Neurophysiol. 58, 160–179 (1987).
Kerr, D. J. B., Ong, J., Prager, R. H., Gynther, B. D. & Curtis, D. R. Brain Res. 405, 150–154 (1987).
Andrade, R., Malenka, R. C. & Nicoll, A. Science 234, 1261–1265 (1986).
Nicoll, R. A. & Alger, B. E. J. Neurosci. Meth. 4, 153–156 (1981).
Ogata, N., Inoue, M. & Matsuo, T. Synapse 1, 62–69 (1987).
Connors, B. W., Gutnick, M. J. & Prince, D. A. J. Neurophysiol. 48, 1302–1320 (1982).
Satou, M., Mori, K., Tazawa, Y. & Takagi, S. J. Neurophys. 48, 1142–1156 (1982).
Mori, K., Nowycky, M. C. & Shephard, G. M. J. Physiol., Lond. 314, 295–309 (1981).
Jahr, C. E. & Nicoll, R. A. J. Physiol. 326, 213–234 (1982).
Howe, J. R., Sutor, B. & Zieglgansberger, W. J. Physiol., Lond. 384, 539–569 (1987).
Avoli, M. Brain Res. 370, 165–170 (1986).
Stevens, D. R., Gallagher, J. P. & Shinnick-Gallagher, P. Synapse 1, 184–190 (1987).
Bowery, N. G., Hudson, A. L. & Price, G. N. Neuroscience 20, 365–383 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dutar, P., Nicoll, R. A physiological role for GABAB receptors in the central nervous system. Nature 332, 156–158 (1988). https://doi.org/10.1038/332156a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/332156a0
This article is cited by
-
Neuronal and synaptic adaptations underlying the benefits of deep brain stimulation for Parkinson's disease
Translational Neurodegeneration (2023)
-
Ethanol blocks a novel form of iLTD, but not iLTP of inhibitory inputs to VTA GABA neurons
Neuropsychopharmacology (2023)
-
Impaired Hypothalamic Regulation of Sympathetic Outflow in Primary Hypertension
Neuroscience Bulletin (2019)
-
Multireceptor fingerprints in progressive supranuclear palsy
Alzheimer's Research & Therapy (2017)
-
The GABAB Positive Allosteric Modulator ADX71441 Attenuates Alcohol Self-Administration and Relapse to Alcohol Seeking in Rats
Neuropsychopharmacology (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.